These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7250167)

  • 1. Haemodynamic reactions after intravenous injection of lorcainide hydrochloride in acute myocardial infarction.
    Shita A; Bernard R; Mostinckx R; Debacker M
    Eur J Cardiol; 1981; 12(5):237-42. PubMed ID: 7250167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemodynamic repercussions and clinical tolerance of 6 class I anti-arrhythmia agents in acute myocardial infarction].
    Bernard R; Renard M; Shita A; de Hemptinne J; Gillet JM; Lewinson H; Liebens I; Waterschoot P
    Ann Cardiol Angeiol (Paris); 1986 Apr; 35(4):195-8. PubMed ID: 3090925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction.
    Leinonen H; Heikkilä J; Sundberg S; Gordin A
    Ann Clin Res; 1984; 16(1):18-22. PubMed ID: 6378045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of korvatone on hemodynamics in the acute stage of myocardial infarct].
    Belov Iu; Daskalov T; Chichovski K; Kusitasev G; Popnikolov S
    Vutr Boles; 1981; 20(5):70-80. PubMed ID: 6895680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lorcainide (R 15 889), a first review.
    Amery WK; Heykants JJ; Xhonneux R; Towse G; Oettel P; Gough DA; Janssen PA
    Acta Cardiol; 1981; 36(3):207-34. PubMed ID: 7020313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lorcainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Eiriksson Ce; Brogden RN
    Drugs; 1984 Apr; 27(4):279-300. PubMed ID: 6373222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of a single intravenous dose of lorcainide in patients with heart disease.
    Meinertz T; Kersting F; Kasper W; Just H; Bechtold H; Jähnchen E
    Eur J Clin Pharmacol; 1980 Nov; 18(6):461-5. PubMed ID: 7461013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of lorcainide.
    Keefe DL
    Am J Cardiol; 1984 Aug; 54(4):18B-21B. PubMed ID: 6465043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemodynamic effects of encainide, flecainide, lorcainide and tocainide.
    Vanhaleweyk G; Serruys PW; Hugenholtz PG
    Eur Heart J; 1984 Sep; 5 Suppl B():67-74. PubMed ID: 6437819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levosimendan improves hemodynamics and coronary flow reserve after percutaneous coronary intervention in patients with acute myocardial infarction and left ventricular dysfunction.
    De Luca L; Proietti P; Celotto A; Bucciarelli-Ducci C; Benedetti G; Di Roma A; Sardella G; Genuini I; Fedele F
    Am Heart J; 2005 Sep; 150(3):563-8. PubMed ID: 16169341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of enzyme induction on the disposition of lorcainide in rats following intravenous and oral administration.
    Plänitz V; Jähnchen E
    Arzneimittelforschung; 1984; 34(6):669-71. PubMed ID: 6541487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous administration of conivaptan hydrochloride improves cardiac hemodynamics in rats with myocardial infarction-induced congestive heart failure.
    Wada K; Fujimori A; Matsukawa U; Arai Y; Sudoh K; Yatsu T; Sasamata M; Miyata K
    Eur J Pharmacol; 2005 Jan; 507(1-3):145-51. PubMed ID: 15659304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HPLC method for determination of lorcainide hydrochloride in human serum].
    Luo X; Zeng FD
    Yao Xue Xue Bao; 1995; 30(8):605-9. PubMed ID: 8571780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
    Somberg JC; Butler B; Flowers D; Keefe D; Torres V; Miura D
    Am J Cardiol; 1984 Aug; 54(4):43B-48B. PubMed ID: 6465046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of lorcainide, a new anti-arrhythmic agent.
    Lloyd EA; Workman LJ; Commerford PJ; Mabin TA
    S Afr Med J; 1981 Dec; 60(24):929-31. PubMed ID: 7302777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circulatory action and adverse effects of 3-carbethoxyamino-5-dimethylamino-acetyl-iminodibenzyl hydrochloride (Bonnecor, AWD 19-166, GS 015) in the dog and cat].
    Poppe H; Femmer K; Kaverina NV; Lyskovzev VV; Grigoreva JK; Mazievskij DD
    Pharmazie; 1985 Dec; 40(12):857-61. PubMed ID: 3841603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of isosorbide dinitrate injection in the acute phase of myocardial infarction. Clinical and haemodynamic study (author's transl)].
    Denis B; Pellet J; Machecourt J; Wolf JE; Dimitriou R; Bouvagnet P
    Nouv Presse Med; 1982 Jun; 11(27):2075-7. PubMed ID: 7110968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
    Touboul P; Kirkorian G; Atallah G; Moleur P
    Ann Cardiol Angeiol (Paris); 1982 Dec; 31(7):531-7. PubMed ID: 6820620
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiarrhythmic effect of lorcainide during chronic treatment.
    Meinertz T; Kasper W; Kersting F; Bechtold H; Just H; Jähnchen E
    Arzneimittelforschung; 1980; 30(9):1593-5. PubMed ID: 7193031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic drug prescription in patients after myocardial infarction in the last decade. Experience of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI).
    Avanzini F; Latini R; Maggioni A; Colombo F; Santoro E; Franzosi MG; Tognoni G
    Arch Intern Med; 1995 May; 155(10):1041-5. PubMed ID: 7748046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.